Objective: To determine the frequency of sepsis and other adverse neonatal outcomes in women with a clinical diagnosis of chorioamnionitis.
Introduction
Current obstetric interventions to reduce early-onset newborn infections, including intrapartum antibiotic prophylaxis for mothers colonized with group B Streptococcus (GBS) and treatment of clinically diagnosed chorioamnionitis, are effective [1, 2] . However, accurate identification of newborns who will develop early-onset sepsis despite these interventions remains a major challenge. For this reason, the American Academy of Pediatrics and the Centers for Disease Control recommend treating asymptomatic infants born to mothers with clinically diagnosed chorioamnionitis with broad-spectrum antibiotics for at least 48 h until infection can be ruled out [3, 4] . As a result of these guidelines, many healthy infants are ultimately treated with empiric antibiotics in order to prevent a single case of sepsis [5] [6] [7] [8] .
Emerging data regarding the adverse consequences of early antibiotic exposure on the developing infant microbiome are worrisome [9] , as is the growing problem of antimicrobial resistance among neonatal pathogens [10] . Furthermore, sepsis evaluations often require neonatal intensive care unit (NICU) admission and/or separation of the mother and infant dyad, potentially disrupting the early establishment of breastfeeding [11] . For these reasons, many experts in the field have called for a reevaluation of the approach to the newborn exposed to maternal chorioamnionitis [5, 12] .
Our objective was to determine, within the current paradigm of intrapartum treatment of clinical chorioamnionitis and empiric newborn treatment after delivery, the associations between clinical chorioamnionitis and earlyonset sepsis and other adverse neonatal outcomes.
Patients and methods
We performed a secondary analysis of a multi-center placebo-controlled randomized trial of vitamins C/E to prevent serious complications associated with pregnancy-associated hypertension in low-risk nulliparous women. The trial, conducted from 2003 to 2008 at 16 clinical centers in the Eunice Kennedy Shriver National Institute of Child and Human Development (NICHD) Maternal-Fetal Medicine Units Network (ClinicalTrials.gov number NCT00135707), has been previously described [13] . Pregnant women who were nulliparous and had a singleton gestation less than 16 weeks 0 days at the time of screening were eligible for inclusion in the trial. A total of 10,154 women underwent randomization to receive capsules containing a combination of 1000 mg of vitamin C (ascorbic acid) and 400 IU of vitamin E (RRR-alpha-tocopherol acetate) or matching placebo (mineral oil). Data were collected by trained and certified research personnel. The study was approved by the Institutional Review Board at each clinical site and the data-coordinating center, and all participants provided written informed consent before enrollment.
A total of 10,154 women were enrolled in the trial. This secondary analysis was restricted to women with outcome data (n = 9969, 98%) who labored (n = 9585, 94.4%). Excluded from the analysis were those with missing data regarding chorioamnionitis status (n = 87, 0.86%) or neonatal sepsis status (n = 9, 0.09%). Also excluded were fetal deaths that occurred prior to the intrapartum period (n = 98, 0.97%). Clinical chorioamnionitis was defined as either the "clinical diagnosis" of chorioamnionitis or the administration of antibiotics during labor because of either an elevated temperature or uterine tenderness in the absence of another cause. Maternal fever during labor was defined as a temperature ≥38.0°C. Early-onset neonatal sepsis (within the first 72 h after birth) was categorized as suspected or confirmed. Confirmed early-onset sepsis included those infants with positive cultures of blood, cerebrospinal fluid or urine from the first 72 h after birth with or without suspicious clinical findings of infection on physical examination or (in the absence of positive cultures) there is clinical evidence of cardiovascular collapse or an unequivocal X-ray confirming infection in an infant who is believed to be clinically septic. Suspected sepsis included those infants who developed clinical findings suspicious for infection on physical examination within the first 72 h after birth with negative cultures and non-confirmatory X-rays. Simply being at risk for sepsis did not meet the necessary criteria for suspected sepsis. Lateonset neonatal sepsis was suspected or confirmed beyond the first 72 h after birth. Bronchopulmonary dysplasia (BPD) was diagnosed when an infant received oxygen therapy [with or without mechanical ventilation/continuous positive airway pressure (CPAP)] and had an oxygen requirement (FiO 2 > 0.21) for the first 28 days of life. A clinical diagnosis of necrotizing enterocolitis (NEC) was made, regardless of the stage, by any of the following findings being observed at surgery or autopsy: (1) the unequivocal presence of intramural air on abdominal X-ray, (2) perforation seen on abdominal X-ray, clinical evidence as suggested by erythema and induration of the abdominal wall, or intra-abdominal abscess formation or (3) stricture formation following an episode of suspected NEC. The presence of seizures was per the diagnosis of seizures in medical record.
Statistical analysis
Descriptive analyses used the chi-squared (χ 2 ) test or Fisher's exact test for categorical variables and the Wilcoxon rank sum test for continuous variables to compare characteristics by maternal chorioamnionitis status. We also conducted analyses to describe the frequency of early-onset sepsis by gestational age at delivery and by choriamnionitis status with and without fever. Early-onset sepsis was evaluated as a dichotomous outcome (combined suspected and confirmed, none) and as a multinomial outcome (confirmed, suspected, none). Due to small numbers, late-onset sepsis was only evaluated as a dichotomous outcome (combined suspected and confirmed, none) without further separation of confirmed and suspected. One and 5 min Apgar scores were evaluated as multinomial outcomes (≤3, [4] [5] [6] [7] [8] [9] [10] ; all other secondary outcomes were evaluated as dichotomous outcomes. The association between each dichotomous neonatal outcome and chorioamnionitis status was evaluated using multivariable logistic regression yielding odds ratios (ORs) and 95% confidence intervals (CIs) after adjusting for years of education, time from membrane rupture to delivery, gestational age at delivery, vitamin C, E or placebo treatment group, race/ethnicity, smoking, type of labor and delivery mode. Multinomial multivariable logistic regression was used for the outcomes with more than two categories. Because deaths that occur prior to NICU admission (intrapartum stillbirths and deaths in the delivery room) are competing outcomes with neonatal sepsis, we conducted a sensitivity analysis in which the outcome was neonatal sepsis or death before NICU admission. Finally, we evaluated the association between sepsis and maximum maternal temperature during labor using multivariable logistic regression. SAS software (SAS Institute, Cary, NC, USA) was used for the analyses. All tests were two-tailed and P < 0.05 was used to define statistical significance. No imputation for missing data was performed. Adjustment for multiple comparisons was not performed.
Results
Data from 9391 mother-infant pairs were analyzed. The frequency of clinical chorioamnionitis was 10.3% (970 women), and ranged from 15.5% with delivery before 34 weeks' gestation to 6.2% in women delivering 34 0/7 -36 6/7 weeks, 9.5% in women delivering 37 0/7 -40 6/7 weeks and 15.7% at ≥41 weeks of gestation. In a univariable analysis, several maternal characteristics were associated with chorioamnionitis including race, uninsured or governmentassisted insurance, education level, duration of membrane rupture and advanced gestational age (Table 1) .
Overall, 620 infants were diagnosed with early-onset sepsis (6.6%). Sixteen infants (0.2%) had confirmed sepsis and 604 (6.4%) were diagnosed with suspected sepsis. The frequency of confirmed or suspected early-onset sepsis decreased with increasing gestational age, affecting 30.2% of preterm neonates and 4.5% of those ≥37 weeks of gestation ( Table 2 ). The most commonly isolated organisms in confirmed cases of sepsis were GBS in term infants and Escherichia coli in preterm infants, regardless of maternal chorioamnionitis status (Table S1) .
Maternal fever during labor (temperature ≥38°C) was observed in 11.8% of the women (81.2% in the women with chorioamnionitis and 3.6% in the women without chorioamnionitis). Unadjusted infectious outcomes by chorioamnionitis and fever status showed the highest OR for confirmed early-onset sepsis in infants born to mothers with both chorioamnionitis and fever during labor (Table 3 ). An increased odds of confirmed early-onset sepsis was observed with increasing maternal temperature; adjusted OR (95% CI) 0. (Table 3) . Seizures, BPD, lateonset sepsis, NEC and intraventricular hemorrhage were not significantly associated with maternal chorioamnionitis. The multivariable analysis results were similar in the sensitivity analyses that considered intrapartum stillbirth Table 2 : Confirmed or suspected early-onset sepsis by gestational age.
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Gestational age at delivery n (%) 
Discussion
The diagnosis of clinical chorioamnionitis is common, and infants born to women with chorioamnionitis are at risk for sepsis and other neonatal morbidities. While the overall incidence of early-onset sepsis (both confirmed and suspected) in our study population is higher than previously reported [6, 14] , the incidence of confirmed earlyonset sepsis in chorioamnionitis-exposed infants is very low (0.7%) and is consistent with the recent literature [5, [15] [16] [17] [18] . Of note, the association between confirmed earlyonset sepsis and chorioamnionitis was statistically significant only if maternal fever was present, which could be partially explained by the importance of precise diagnostic criteria, or may be explained by the small sample size when stratifying chorioamnionitis by the presence or absence of maternal fever. Infants born to mothers with chorioamnionitis were nearly 3 times as likely to be diagnosed with suspected sepsis (a diagnosis that required the presence of suspicious clinical findings) compared with those who were unexposed. Commonly used blood culture media may be inadequate to detect fastidious microbes or obligate anaerobic organisms, as demonstrated in a recent study by Mukhopadhyay and Puopolo [19] . Another possible contributing factor is clinicians' lower threshold to diagnose suspected newborn sepsis in the setting of ambiguous/equivocal physical examination findings or abnormal screening laboratory values with antenatal risk factors such as chorioamnionitis, intrapartum fever, inadequate antibiotic therapy for GBS colonization or prolonged membrane rupture. There is considerable heterogeneity in the literature regarding the definition of culture-negative sepsis and the lack of a neonatal-specific consensus Adjusted for years of education, time from membrane rupture to delivery (log), gestational age at delivery (linear and quadratic terms), treatment group, race/ ethnicity, smoking, type of labor and delivery mode; a total of 194 patients had missing data on one or more of the adjustment variables. definition renders the study of this condition and its associated risk factors problematic [20, 21] .
Despite current practices regarding intrapartum antibiotic treatment, gestational age at delivery remains an important consideration when assessing risk for earlyonset sepsis, particularly in the setting of chorioamnionitis [22, 23] . Chorioamnionitis was more commonly diagnosed in those mothers who delivered <34 weeks' gestation and at ≥41 weeks' gestation. As expected, the frequency of confirmed or suspected early-onset sepsis was highest in the preterm neonates (30.2%) and was substantially lower (4.5%) in those born at term.
In this study, BPD and NEC were not significantly associated with a diagnosis of maternal chorioamnionitis; however, our sample size limited our ability to adequately evaluate rare outcomes. Previous reports investigating the association between these specific morbidities and chorioamnionitis have yielded conflicting results [24] [25] [26] [27] . This may reflect inconsistent case definitions as well as variability of fetal exposure with regard to extent, severity and timing of infectious insult [28] [29] [30] .
Another limitation of this study is that we cannot determine the true risk of culture-negative sepsis in infants born to women with a diagnosis of chorioamnionitis given the current standard of care to treat all exposed newborns with empiric antibiotics. It is possible that a brief course of antimicrobial therapy (48-72 h) may effectively treat some infants who would have otherwise developed sepsis.
A major strength of this study is its generalizability, as these data were derived from a large, ethnically diverse, multicenter patient population. The definition of chorioamnionitis used for this study (a clinical diagnosis of chorioamnionitis by the obstetric provider or if antibiotics were administered during labor due to an elevated body temperature or uterine tenderness with no other defined infection) is reflective of current practice in most US hospitals. Greenberg et al. [31] examined variation in US obstetrical management of patients with chorioamnionitis and noted that the diagnosis of clinical chorioamnionitis is frequently made in the presence of maternal fever alone (26%) or with the presence of only one additional criterion (61%). This lack of precision in the diagnosis of chorioamnionitis remains a challenge for clinicians and investigators alike. The term was initially intended to describe the histopathologic changes in the chorion and/or amnion observed in the presence of inflammation [32] . It has become increasingly apparent that histologic inflammation and clinical signs of infection do not always overlap [33] [34] [35] [36] [37] . In 1980, a clinical definition for chorioamnionitis was proposed [38] . This definition required the presence of maternal fever and two additional clinical findings suggestive of intrauterine infection. The initial epidemiologic studies linking maternal chorioamnionitis with neonatal sepsis utilized these strict diagnostic criteria. In 2015, a NICHD workshop was convened in order to provide evidence-based guidelines for the diagnosis and management of pregnant women with chorioamnionitis [12] . This expert panel acknowledged the imprecise and heterogeneous nature of the term chorioamnionitis and recommended it be replaced with "intrauterine inflammation or infection or both (Triple I)" [12] . The use of this more descriptive term may assist clinicians in accurately identifying those neonates most at risk for sepsis. Data collected for this study do not allow us to determine what proportion of women diagnosed with chorioamnionitis would meet the proposed Triple I criteria.
Emerging data suggest that reliance on serial physical examinations rather than screening laboratory tests may better identify infected neonates [39] [40] [41] . Recently proposed strategies that combine a rigorous assessment of maternal risk factors together with the neonate's clinical presentation, such as that described by Escobar et al. [42] may provide the most accurate estimate of the probability of sepsis in at-risk newborns. Because the likelihood of sepsis in well-appearing term newborns is exceedingly low, incorporation of the infant's physical examination into their risk assessment algorithm significantly reduced the number of healthy newborns exposed to empiric antibiotics therapy [42] . Such an approach may be preferable given our findings that the vast majority of term infants delivered in the setting of maternal chorioamnionitis do not have culture-proven infection. Finally, the discovery and validation of novel biomarkers to assess the risk of newborn sepsis remains an important research initiative [12] .
Conclusion
The diagnosis of clinical chorioamnionitis is common and is associated with neonatal morbidities. However, the vast majority of exposed infants (99.3%) do not have confirmed early-onset sepsis. Identification of those infants most at risk remains a diagnostic challenge.
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